Corient Private Wealth LLC Has $201,000 Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Corient Private Wealth LLC boosted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCOFree Report) by 37.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,155 shares of the company’s stock after acquiring an additional 5,811 shares during the period. Corient Private Wealth LLC’s holdings in AdaptHealth were worth $201,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AHCO. Assetmark Inc. bought a new position in shares of AdaptHealth during the 4th quarter valued at about $28,000. Blue Trust Inc. raised its holdings in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after buying an additional 1,115 shares during the period. Quarry LP lifted its stake in AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after buying an additional 5,838 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after buying an additional 1,690 shares in the last quarter. Finally, LRI Investments LLC boosted its holdings in shares of AdaptHealth by 32.0% in the third quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock valued at $172,000 after buying an additional 3,713 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Stock Performance

NASDAQ AHCO opened at $10.82 on Wednesday. The stock has a market cap of $1.46 billion, a PE ratio of -6.56, a P/E/G ratio of 1.08 and a beta of 1.30. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a 50-day moving average of $10.03 and a 200-day moving average of $10.16. AdaptHealth Corp. has a 52-week low of $8.35 and a 52-week high of $11.90.

Analyst Ratings Changes

AHCO has been the topic of a number of research analyst reports. UBS Group dropped their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Robert W. Baird lifted their price target on AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Truist Financial upped their price objective on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Canaccord Genuity Group raised their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Finally, Royal Bank of Canada boosted their price target on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $13.80.

Read Our Latest Stock Analysis on AHCO

AdaptHealth Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Further Reading

Want to see what other hedge funds are holding AHCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdaptHealth Corp. (NASDAQ:AHCOFree Report).

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.